{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"peginesatide","name":"Peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":34,"objects":{"clinicaltrials-gov-nct00097747-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00097747-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00097747-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00097747-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00097747-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00097747-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00097747-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2012-12-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00097747","sourceIds":["ctg-observation-nct00097747-2012-12-21-94d632b0d309"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00097747 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00097747-2012-12-21-94d632b0d309"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00097747 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00097747-2012-12-21-94d632b0d309"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00097747-2012-12-21-94d632b0d309"]}],"sources":[{"id":"ctg-observation-nct00097747-2012-12-21-94d632b0d309","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00097747 · retained source version 2012-12-21:94d632b0d30932e9d83b65f0becd193cea0dd9eb7ac85909f4f7cfda4cb10d98","url":"https://clinicaltrials.gov/study/NCT00097747"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c85a797af1edf6eee2037cbca23a7a9321631906c447ae6443c69b277ce751b5","tierARecordSha256":"77466861621c4b721ef03babef20f0617e1fe2fa59c0e6c083b120a51fe33c31"},"integrity":{"algorithm":"sha256","contentSha256":"357064512fbb02b4504acab8582fea53450510e1bc55f6da0b7a5bff24e137f2"}},"clinicaltrials-gov-nct00228436-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00228436-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00228436-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00228436-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00228436-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00228436-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00228436-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2012-12-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00228436","sourceIds":["ctg-observation-nct00228436-2012-12-21-d79c980635eb"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00228436 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00228436-2012-12-21-d79c980635eb"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00228436 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00228436-2012-12-21-d79c980635eb"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00228436-2012-12-21-d79c980635eb"]}],"sources":[{"id":"ctg-observation-nct00228436-2012-12-21-d79c980635eb","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00228436 · retained source version 2012-12-21:d79c980635ebdd8814535d643f53ffd9349bc3c3425ce0477431a1fe5bf169e4","url":"https://clinicaltrials.gov/study/NCT00228436"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d5ceb5682949c26f827d4a2c898ea6efd48428f9b2293640895faf4a8a4cf287","tierARecordSha256":"7006a885cdb84104e4214642648db59441308543f5f6a0937bdf3e37695b6e2c"},"integrity":{"algorithm":"sha256","contentSha256":"bc3b797f5e140077915a9771ac8b58495e5aee0984bab20a21b2470b37e2a9b0"}},"clinicaltrials-gov-nct00228449-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00228449-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00228449-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00228449-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00228449-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00228449-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00228449-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2012-12-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00228449","sourceIds":["ctg-observation-nct00228449-2012-12-21-640e1fc45578"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00228449 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00228449-2012-12-21-640e1fc45578"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00228449 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00228449-2012-12-21-640e1fc45578"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00228449-2012-12-21-640e1fc45578"]}],"sources":[{"id":"ctg-observation-nct00228449-2012-12-21-640e1fc45578","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00228449 · retained source version 2012-12-21:640e1fc455783fb9f5b76c964473b2522548a21cca10cbb2bc6306e3a5359e8e","url":"https://clinicaltrials.gov/study/NCT00228449"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"31f98120cce45c9321b9dd3ec635b00b4004122d876aea4f24f97716c8eb37a2","tierARecordSha256":"96119306c9aa18b043e754d0af1e4211d4f18aa2fa9c9ed38fcca1e420263d4d"},"integrity":{"algorithm":"sha256","contentSha256":"af4f351d80d538f317649d072102009bdd0e5c58e25ea38478c1e3a75ef39e1d"}},"clinicaltrials-gov-nct00272662-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00272662-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00272662-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00272662-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00272662-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00272662-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00272662-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2012-12-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00272662","sourceIds":["ctg-observation-nct00272662-2012-12-21-7ce33d809436"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00272662 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00272662-2012-12-21-7ce33d809436"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00272662 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00272662-2012-12-21-7ce33d809436"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00272662-2012-12-21-7ce33d809436"]}],"sources":[{"id":"ctg-observation-nct00272662-2012-12-21-7ce33d809436","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00272662 · retained source version 2012-12-21:7ce33d80943644f9f1d381593bc71555003363161584765347ac05833e1cd2aa","url":"https://clinicaltrials.gov/study/NCT00272662"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b8a412fd6e29cce8b6778d66feff4579f5e3c2546531d6cd58ff0d432d82e8d6","tierARecordSha256":"79d92af559c274242ef4de000dc8d6b0d4a70f6ebd0af6494cf49b39651c6a02"},"integrity":{"algorithm":"sha256","contentSha256":"83956cf7d22d2cb5b43dc52cf7b8c04fa50a4406d05d35f837ac34476bc4ff56"}},"clinicaltrials-gov-nct00314795-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00314795-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00314795-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00314795-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00314795-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00314795-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00314795-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2019-03-14","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00314795","sourceIds":["ctg-observation-nct00314795-2019-03-14-1c2bd2cbee5a"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00314795 at 2026-11-16T17:45:11.119Z. Its registry update date was 2019-03-14, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00314795-2019-03-14-1c2bd2cbee5a"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00314795 at 2026-11-16T17:45:11.119Z. Its registry update date was 2019-03-14, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00314795-2019-03-14-1c2bd2cbee5a"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00314795-2019-03-14-1c2bd2cbee5a"]}],"sources":[{"id":"ctg-observation-nct00314795-2019-03-14-1c2bd2cbee5a","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00314795 · retained source version 2019-03-14:1c2bd2cbee5a6c6ca3c2fa332f5a27e678f462899f0351b1c404e3bdbec744b0","url":"https://clinicaltrials.gov/study/NCT00314795"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f92de8be6a772e098fc57a44fc1e1d8f8123e5b9593fecfd3fdf6de209549506","tierARecordSha256":"93b3f6301d4c48d8159f7aa0b05d8356e16f4eaa476540a18a424e1d44d54371"},"integrity":{"algorithm":"sha256","contentSha256":"2bd93cf3673aab4ededb3fecc40ec3b27289b0c9610b05a409022f4a3765a61e"}},"clinicaltrials-gov-nct00434330-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00434330-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00434330-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00434330-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00434330-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00434330-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00434330-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2012-06-29","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00434330","sourceIds":["ctg-observation-nct00434330-2012-06-29-aa3ddbd6a809"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00434330 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-06-29, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00434330-2012-06-29-aa3ddbd6a809"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00434330 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-06-29, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00434330-2012-06-29-aa3ddbd6a809"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00434330-2012-06-29-aa3ddbd6a809"]}],"sources":[{"id":"ctg-observation-nct00434330-2012-06-29-aa3ddbd6a809","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00434330 · retained source version 2012-06-29:aa3ddbd6a809e27e4078df9385866a2970cabb930eb0e9a67ae3cda03d5f38ec","url":"https://clinicaltrials.gov/study/NCT00434330"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f3502e21530bd3d40d483c6239353ef1fbc24a378c3d5343a793b9150d5f8c12","tierARecordSha256":"a59a6906e690ac00d269e70dc191d9da6fbf6b9ed6081ac3cd723d584a0c73d1"},"integrity":{"algorithm":"sha256","contentSha256":"9cea56e6ee2f615dabc5ab28ed9ea6e5ec47947ee2d288d9d96d9da5db466c0b"}},"clinicaltrials-gov-nct00597584-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00597584-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00597584-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00597584-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00597584-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00597584-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00597584-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2013-03-08","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00597584","sourceIds":["ctg-observation-nct00597584-2013-03-08-fdbfc6373e59"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00597584 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-03-08, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00597584-2013-03-08-fdbfc6373e59"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00597584 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-03-08, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00597584-2013-03-08-fdbfc6373e59"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00597584-2013-03-08-fdbfc6373e59"]}],"sources":[{"id":"ctg-observation-nct00597584-2013-03-08-fdbfc6373e59","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00597584 · retained source version 2013-03-08:fdbfc6373e598b4814cdb52de6c2d23028240b618f407eaf1cb887136ef6218d","url":"https://clinicaltrials.gov/study/NCT00597584"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"37cf2f6da4bf7af8d6302fc5cf9ef7345290a1a7afcb8876e45d6039cbe05075","tierARecordSha256":"d710277c83309da6a9099c8603e15f6a1bf8704a5730e201afa646cdc9fab93b"},"integrity":{"algorithm":"sha256","contentSha256":"4a5f220bb0ef222e9f5ea39a9cd7031dfb7d1e35c27ba19a77b7ab1bacb30b5a"}},"clinicaltrials-gov-nct00597753-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00597753-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00597753-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00597753-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00597753-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00597753-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00597753-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2013-02-12","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00597753","sourceIds":["ctg-observation-nct00597753-2013-02-12-f30eace3c272"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00597753 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00597753-2013-02-12-f30eace3c272"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00597753 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00597753-2013-02-12-f30eace3c272"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00597753-2013-02-12-f30eace3c272"]}],"sources":[{"id":"ctg-observation-nct00597753-2013-02-12-f30eace3c272","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00597753 · retained source version 2013-02-12:f30eace3c27265c0f357deac9ffbfd13bcfa1e36f19b18459767727a21b2f5fb","url":"https://clinicaltrials.gov/study/NCT00597753"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0c26ce3297736afb27d03a66bbf225b484a9ef6e1fcb7ae1308657166304ae0d","tierARecordSha256":"091f71d9f7d00c830e8207f7bbe85f7c337d2704d7a2c51fc8f8cc156afcea62"},"integrity":{"algorithm":"sha256","contentSha256":"fe1f0459a7ed3e2e63dece215d919e0a2aad6be98334ed5d726cea1265c19a36"}},"clinicaltrials-gov-nct00598273-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00598273-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00598273-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00598273-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00598273-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00598273-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00598273-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2013-02-12","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00598273","sourceIds":["ctg-observation-nct00598273-2013-02-12-28fe8bf9ee53"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00598273 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00598273-2013-02-12-28fe8bf9ee53"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00598273 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00598273-2013-02-12-28fe8bf9ee53"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00598273-2013-02-12-28fe8bf9ee53"]}],"sources":[{"id":"ctg-observation-nct00598273-2013-02-12-28fe8bf9ee53","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00598273 · retained source version 2013-02-12:28fe8bf9ee537c54227b56fe0e0aed4ffdae3a85541d35c8f63304eb7bf9e81f","url":"https://clinicaltrials.gov/study/NCT00598273"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"588e06d9c3c4743c71e7dbb6fd9b3d3999063a4fe7172a45f6dbc1d16fbb9f3f","tierARecordSha256":"c14d9b1e08ba9534b912595b864001c34a532a811b508a8eec433b6fc01fe300"},"integrity":{"algorithm":"sha256","contentSha256":"c39eb67d035a8d70b89b42b05849570d94cf7b3076485d7fb37ddaa0dd54cead"}},"clinicaltrials-gov-nct00598442-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00598442-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00598442-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00598442-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00598442-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00598442-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00598442-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2013-02-12","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00598442","sourceIds":["ctg-observation-nct00598442-2013-02-12-961162cb85af"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00598442 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00598442-2013-02-12-961162cb85af"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00598442 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00598442-2013-02-12-961162cb85af"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00598442-2013-02-12-961162cb85af"]}],"sources":[{"id":"ctg-observation-nct00598442-2013-02-12-961162cb85af","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00598442 · retained source version 2013-02-12:961162cb85afa994730788184d79e314792ce06ba31e215f9360c08261360cda","url":"https://clinicaltrials.gov/study/NCT00598442"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"32c9192070269ea03db268822ea3a6f6ff4b1790a00c67c1777e10544471ec48","tierARecordSha256":"cba2b2579d17fe7ab9292954457e6b25067012f5953944cb8d81074fb83d712a"},"integrity":{"algorithm":"sha256","contentSha256":"13acf95f862972f3bcc8b6fe50a99545ae1a43334be27554c48b968b857b02d2"}},"clinicaltrials-gov-nct00680043-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00680043-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00680043-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00680043-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00680043-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00680043-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00680043-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2012-06-29","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00680043","sourceIds":["ctg-observation-nct00680043-2012-06-29-d3db87297425"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00680043 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-06-29, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00680043-2012-06-29-d3db87297425"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00680043 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-06-29, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00680043-2012-06-29-d3db87297425"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00680043-2012-06-29-d3db87297425"]}],"sources":[{"id":"ctg-observation-nct00680043-2012-06-29-d3db87297425","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00680043 · retained source version 2012-06-29:d3db87297425c593bbe09a04d120b85df6bed28d7714146ca6a71a462746d5d0","url":"https://clinicaltrials.gov/study/NCT00680043"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1949c7a04f490285e6f4ef205a4b3f4cc505483bea9d25975e26c117a8d7cd87","tierARecordSha256":"73a095f800cb7dcb4d81ba7a26fd6b4a984d052d7779a6424b84709863a5db15"},"integrity":{"algorithm":"sha256","contentSha256":"7622fc58b172c70347498be420a42ff3457a07512a25b9140412c25d049c1505"}},"clinicaltrials-gov-nct00752609-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00752609-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00752609-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00752609-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00752609-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00752609-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00752609-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2012-07-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00752609","sourceIds":["ctg-observation-nct00752609-2012-07-27-664b1ad23677"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00752609 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-07-27, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00752609-2012-07-27-664b1ad23677"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00752609 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-07-27, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00752609-2012-07-27-664b1ad23677"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00752609-2012-07-27-664b1ad23677"]}],"sources":[{"id":"ctg-observation-nct00752609-2012-07-27-664b1ad23677","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00752609 · retained source version 2012-07-27:664b1ad23677e98e3d3d6f9641ca9536406b199e34712677bc5d9679a9ab3082","url":"https://clinicaltrials.gov/study/NCT00752609"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"02437f0ca02331a0250341d3ab8471c38a0661117b1d80364480e672304cb78e","tierARecordSha256":"abaab67f98aca7f268273f2bbb401e35d2359b8d37cb138243a3305872eea069"},"integrity":{"algorithm":"sha256","contentSha256":"1cbb8d0b86b56a54cedabab9e266aba38b407064971857140b028f84d45a2e0a"}},"clinicaltrials-gov-nct00752791-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00752791-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct00752791-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00752791-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct00752791-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct00752791-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct00752791-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2012-08-15","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00752791","sourceIds":["ctg-observation-nct00752791-2012-08-15-86b30643d3fa"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00752791 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-08-15, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00752791-2012-08-15-86b30643d3fa"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00752791 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-08-15, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct00752791-2012-08-15-86b30643d3fa"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00752791-2012-08-15-86b30643d3fa"]}],"sources":[{"id":"ctg-observation-nct00752791-2012-08-15-86b30643d3fa","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00752791 · retained source version 2012-08-15:86b30643d3fa54f8b252e834df750d8347b00abcdfb5a791858801136a75dcbe","url":"https://clinicaltrials.gov/study/NCT00752791"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f24dfd1ed7108670dd321df82589d823706764ca3c28a11368d13cd70cafa90d","tierARecordSha256":"baa4b338607df2af312c706762a65e1b258582dd23b245ac02964b2c511513c2"},"integrity":{"algorithm":"sha256","contentSha256":"e9c06fd88f3382134d4c3d73c28ebf3a4d17c595370a59dba5636bec7bcc5d82"}},"clinicaltrials-gov-nct01478971-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01478971-peginesatide:v1","objectPathId":"clinicaltrials-gov-nct01478971-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01478971-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#clinicaltrials-gov-nct01478971-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#clinicaltrials-gov-nct01478971-peginesatide-v1"},"story":{"slug":"clinicaltrials-gov-nct01478971-peginesatide","version":1,"domain":"Clinical trials","dateInSource":"2016-09-20","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01478971","sourceIds":["ctg-observation-nct01478971-2016-09-20-f9be6822258a"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01478971 at 2026-11-16T17:45:11.119Z. Its registry update date was 2016-09-20, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct01478971-2016-09-20-f9be6822258a"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01478971 at 2026-11-16T17:45:11.119Z. Its registry update date was 2016-09-20, and PeptideScanner's reviewed identity mapping was peginesatide.","sourceIds":["ctg-observation-nct01478971-2016-09-20-f9be6822258a"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01478971-2016-09-20-f9be6822258a"]}],"sources":[{"id":"ctg-observation-nct01478971-2016-09-20-f9be6822258a","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01478971 · retained source version 2016-09-20:f9be6822258a932ab7f2d3ec7acddf879ee628aecbda545a3192d03522b30cbe","url":"https://clinicaltrials.gov/study/NCT01478971"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c003ed3f42c0a490d9105a6ba3c072eb3d15b10b6504b9b7e483cd784a152222","tierARecordSha256":"76fd2ab57b83d9a42d43caa76b134d53ea86fc35aefbc5d6d7646b7925bdeca6"},"integrity":{"algorithm":"sha256","contentSha256":"066f10add7cae2cb312e116592bfc7f001b208740a16390b10d957c0154a3ee8"}},"fda-drugs-nda202799-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda202799:v1","objectPathId":"fda-drugs-nda202799-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda202799/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#fda-drugs-nda202799-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#fda-drugs-nda202799-v1"},"story":{"slug":"fda-drugs-nda202799","version":1,"domain":"Regulatory","dateInSource":"2012-03-27","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA202799","sourceIds":["fda-drugs-nda202799-2012-03-27-02eb35891ff6"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 202799 with status AP dated 2012-03-27, and names peginesatide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda202799-2012-03-27-02eb35891ff6"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 202799 with status AP dated 2012-03-27, and names peginesatide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda202799-2012-03-27-02eb35891ff6"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda202799-2012-03-27-02eb35891ff6"]}],"sources":[{"id":"fda-drugs-nda202799-2012-03-27-02eb35891ff6","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA202799 · original submission status AP · 2012-03-27 · dataset 2026-11-16","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA202799%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"55e49a0f084972d3893d0887712ce6bcfa6af59f78bf892f51f1f39b0946ffc8","tierARecordSha256":"02eb35891ff643a2d4a90504a65edaf45a2c90e30ebdd35629510bd1c8d24bcd"},"integrity":{"algorithm":"sha256","contentSha256":"b983e932de91d3959fec3f25890a10aaf11151456af439b3fc274d563494e6d5"}},"federal-register-2011-27327-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2011-27327:v1","objectPathId":"federal-register-2011-27327-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2011-27327/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#federal-register-2011-27327-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#federal-register-2011-27327-v1"},"story":{"slug":"federal-register-2011-27327","version":1,"domain":"Regulatory","dateInSource":"2011-10-24","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2011-27327","sourceIds":["federal-register-2011-27327-0d5a3ae35e5d"]},{"id":"summary","text":"The Federal Register published notice 2011-27327, attributed to FDA and its parent HHS department, on 2011-10-24. Its official title is “Oncologic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.","sourceIds":["federal-register-2011-27327-0d5a3ae35e5d"]},{"id":"paragraph-1","text":"The Federal Register published notice 2011-27327, attributed to FDA and its parent HHS department, on 2011-10-24. Its official title is “Oncologic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.","sourceIds":["federal-register-2011-27327-0d5a3ae35e5d"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2011-27327-0d5a3ae35e5d"]}],"sources":[{"id":"federal-register-2011-27327-0d5a3ae35e5d","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2011-27327 · published 2011-10-24 · Oncologic Drugs Advisory Committee; Notice of Meeting","url":"https://www.govinfo.gov/content/pkg/FR-2011-10-24/pdf/2011-27327.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6e27010ce6ef5814773d061f674cd844f2aba0e47ba55083080509b53ab99cbe","tierARecordSha256":"0d5a3ae35e5d6ff8c2c4a7acc912f6207ee3dd4cd5e70a2a61e5118c41a11fc4"},"integrity":{"algorithm":"sha256","contentSha256":"d56c7091b9632cf8aafe7ca114f7643bcb08ef9b7a16e54428cce6859e204b4a"}},"federal-register-2014-11523-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2014-11523:v1","objectPathId":"federal-register-2014-11523-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2014-11523/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#federal-register-2014-11523-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#federal-register-2014-11523-v1"},"story":{"slug":"federal-register-2014-11523","version":1,"domain":"Regulatory","dateInSource":"2014-05-20","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2014-11523","sourceIds":["federal-register-2014-11523-b0c303a07802"]},{"id":"summary","text":"The Federal Register published notice 2014-11523, attributed to FDA and its parent HHS department, on 2014-05-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OMONTYS,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.","sourceIds":["federal-register-2014-11523-b0c303a07802"]},{"id":"paragraph-1","text":"The Federal Register published notice 2014-11523, attributed to FDA and its parent HHS department, on 2014-05-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OMONTYS,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.","sourceIds":["federal-register-2014-11523-b0c303a07802"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2014-11523-b0c303a07802"]}],"sources":[{"id":"federal-register-2014-11523-b0c303a07802","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2014-11523 · published 2014-05-20 · Determination of Regulatory Review Period for Purposes of Patent Extension; OMONTYS","url":"https://www.govinfo.gov/content/pkg/FR-2014-05-20/pdf/2014-11523.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a280ba03b5677dfb728d36fd56361157ff4cea9a0591e52c6dcf0641277c57ec","tierARecordSha256":"b0c303a07802a9627e0c6e759b740ac0c39b8bd6c3b6e2ac7b20d1722978a220"},"integrity":{"algorithm":"sha256","contentSha256":"72ef41ba64d92cae4ddef1141952962f4d660f55332dee030c7799f577551d91"}},"federal-register-2019-02146-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2019-02146:v1","objectPathId":"federal-register-2019-02146-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2019-02146/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#federal-register-2019-02146-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#federal-register-2019-02146-v1"},"story":{"slug":"federal-register-2019-02146","version":1,"domain":"Regulatory","dateInSource":"2019-02-13","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2019-02146","sourceIds":["federal-register-2019-02146-8c1eb3bcb948"]},{"id":"summary","text":"The Federal Register published notice 2019-02146, attributed to FDA and its parent HHS department, on 2019-02-13. Its official title is “Takeda Pharmaceuticals U.S.A., Inc.; Withdrawal of Approval of a New Drug Application for OMONTYS (peginesatide) Injection,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.","sourceIds":["federal-register-2019-02146-8c1eb3bcb948"]},{"id":"paragraph-1","text":"The Federal Register published notice 2019-02146, attributed to FDA and its parent HHS department, on 2019-02-13. Its official title is “Takeda Pharmaceuticals U.S.A., Inc.; Withdrawal of Approval of a New Drug Application for OMONTYS (peginesatide) Injection,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.","sourceIds":["federal-register-2019-02146-8c1eb3bcb948"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2019-02146-8c1eb3bcb948"]}],"sources":[{"id":"federal-register-2019-02146-8c1eb3bcb948","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2019-02146 · published 2019-02-13 · Takeda Pharmaceuticals U.S.A., Inc.; Withdrawal of Approval of a New Drug Application for OMONTYS (peginesatide) Injection","url":"https://www.govinfo.gov/content/pkg/FR-2019-02-13/pdf/2019-02146.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8bb7509ed529b54a6b79afa85e17cb782b408d13ecbc4d104cb87eec1e88842e","tierARecordSha256":"8c1eb3bcb94855cbb8d0c6bb9042681ec2f4639b4d8f4b34db0a254135b81d54"},"integrity":{"algorithm":"sha256","contentSha256":"4136406c2182a586430dab55593288d6c64f9d7458f9d41430e31a3599cd92c3"}},"pubmed-pmid-21816551-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-21816551-peginesatide:v1","objectPathId":"pubmed-pmid-21816551-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-21816551-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-21816551-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-21816551-peginesatide-v1"},"story":{"slug":"pubmed-pmid-21816551-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2017-11-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.","sourceIds":["pubmed-observation-pmid-21816551-2017-11-16-5f09a642fa6f"]},{"id":"summary","text":"PubMed lists PMID 21816551 in Forensic science international as Journal Article, with publication-date metadata of 2011-08-03 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21816551-2017-11-16-5f09a642fa6f"]},{"id":"paragraph-1","text":"PubMed lists PMID 21816551 in Forensic science international as Journal Article, with publication-date metadata of 2011-08-03 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21816551-2017-11-16-5f09a642fa6f"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-21816551-2017-11-16-5f09a642fa6f"]}],"sources":[{"id":"pubmed-observation-pmid-21816551-2017-11-16-5f09a642fa6f","name":"PubMed","sourceClass":"A","title":"Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples. · retained source version 1:2017-11-16:current:5f09a642fa6f0ddb67a388aebff9b89aca8056a7595caac66d372381da801773","url":"https://pubmed.ncbi.nlm.nih.gov/21816551/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"08e38a8db21d3309c61930c9c1995bae4859312c495adc27aa40e1b5ffc9013e","tierARecordSha256":"0a5b789829e7207e57b3e3aec2ce960572c534ac5857b622343879ba3f4b19ad"},"integrity":{"algorithm":"sha256","contentSha256":"737231c5a87df384a22cb363c9a8cd05fdf03a1e82f5c713f3d12a4729f1d2e6"}},"pubmed-pmid-22592927-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-22592927-peginesatide:v1","objectPathId":"pubmed-pmid-22592927-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-22592927-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-22592927-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-22592927-peginesatide-v1"},"story":{"slug":"pubmed-pmid-22592927-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2019-12-10","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing.","sourceIds":["pubmed-observation-pmid-22592927-2019-12-10-8d1f70631133"]},{"id":"summary","text":"PubMed lists PMID 22592927 in Analytical and bioanalytical chemistry as Journal Article, Research Support, Non-U.S. Gov't, Validation Study, with publication-date metadata of 2012-05-17 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22592927-2019-12-10-8d1f70631133"]},{"id":"paragraph-1","text":"PubMed lists PMID 22592927 in Analytical and bioanalytical chemistry as Journal Article, Research Support, Non-U.S. Gov't, Validation Study, with publication-date metadata of 2012-05-17 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22592927-2019-12-10-8d1f70631133"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-22592927-2019-12-10-8d1f70631133"]}],"sources":[{"id":"pubmed-observation-pmid-22592927-2019-12-10-8d1f70631133","name":"PubMed","sourceClass":"A","title":"Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing. · retained source version 1:2019-12-10:current:8d1f70631133616796877c199150f7f7789d56e08dd1c580ee048d584101a9b1","url":"https://pubmed.ncbi.nlm.nih.gov/22592927/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"607dd5cfa2a69f708ad1917eeadc6bc89be3201b1b292234e6bfe3f2424dc73d","tierARecordSha256":"40a8d64e8f8580019a6989446238529c41d24d4eee7c821f2c230826e4077778"},"integrity":{"algorithm":"sha256","contentSha256":"60b51ff2007e2f20c1b5605aaa556665f8b7887f3018c1b1c28aaa874d666cf7"}},"pubmed-pmid-22683926-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-22683926-peginesatide:v1","objectPathId":"pubmed-pmid-22683926-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-22683926-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-22683926-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-22683926-peginesatide-v1"},"story":{"slug":"pubmed-pmid-22683926-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2026-01-28","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide (Omontys) for anemia in chronic kidney failure.","sourceIds":["pubmed-observation-pmid-22683926-2026-01-28-06808a4e50ab"]},{"id":"summary","text":"PubMed lists PMID 22683926 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2012-06-11 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22683926-2026-01-28-06808a4e50ab"]},{"id":"paragraph-1","text":"PubMed lists PMID 22683926 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2012-06-11 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22683926-2026-01-28-06808a4e50ab"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-22683926-2026-01-28-06808a4e50ab"]}],"sources":[{"id":"pubmed-observation-pmid-22683926-2026-01-28-06808a4e50ab","name":"PubMed","sourceClass":"A","title":"Peginesatide (Omontys) for anemia in chronic kidney failure. · retained source version 1:2026-01-28:current:06808a4e50abc77dc5f6a9f2bfb0f807871f339b71bcf1ea60a3abd030b8dd54","url":"https://pubmed.ncbi.nlm.nih.gov/22683926/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fcbaf948e499b940e15ffba4d9dc913ffca21839c08c87272ef164bef1d3a4e1","tierARecordSha256":"69e8e9f8cb536db08da83bfa44121dcadf1dbcbd92031c0f490428f91f9830a9"},"integrity":{"algorithm":"sha256","contentSha256":"06e35b89acaffda9b55eaf7d4060341ae611799c3e87170139e258c718959843"}},"pubmed-pmid-22745925-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-22745925-peginesatide:v1","objectPathId":"pubmed-pmid-22745925-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-22745925-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-22745925-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-22745925-peginesatide-v1"},"story":{"slug":"pubmed-pmid-22745925-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2018-12-01","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide for the treatment of anemia in the nephrology setting.","sourceIds":["pubmed-observation-pmid-22745925-2018-12-01-bcb406c7320b"]},{"id":"summary","text":"PubMed lists PMID 22745925 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, with publication-date metadata of 2012-06 (month precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22745925-2018-12-01-bcb406c7320b"]},{"id":"paragraph-1","text":"PubMed lists PMID 22745925 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, with publication-date metadata of 2012-06 (month precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22745925-2018-12-01-bcb406c7320b"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-22745925-2018-12-01-bcb406c7320b"]}],"sources":[{"id":"pubmed-observation-pmid-22745925-2018-12-01-bcb406c7320b","name":"PubMed","sourceClass":"A","title":"Peginesatide for the treatment of anemia in the nephrology setting. · retained source version 1:2018-12-01:current:bcb406c7320bfa3ca9da5a31bcdcd323f819db32477d1200e6c57a8ec901124c","url":"https://pubmed.ncbi.nlm.nih.gov/22745925/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1c60640020411e95c23b97347a3fcdeb5a87de6f6942531ff7dd2ee45aa6c9fc","tierARecordSha256":"4f0083008ddd72e56494e93edea4476d5ee3067aa7533ce534c13cd50b0de153"},"integrity":{"algorithm":"sha256","contentSha256":"51868b0fa06c52aa7734cc8bd0d6ba282ae87b22a23bc9de69c3a4c11cbabcce"}},"pubmed-pmid-23023854-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23023854-peginesatide:v1","objectPathId":"pubmed-pmid-23023854-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23023854-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-23023854-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-23023854-peginesatide-v1"},"story":{"slug":"pubmed-pmid-23023854-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2026-11-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide acetate, axitinib, and pertuzumab.","sourceIds":["pubmed-observation-pmid-23023854-2026-11-09-09dc80e204af"]},{"id":"summary","text":"PubMed lists PMID 23023854 in Journal of the American Pharmacists Association : JAPhA as Journal Article, Review, with publication-date metadata of 2012 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23023854-2026-11-09-09dc80e204af"]},{"id":"paragraph-1","text":"PubMed lists PMID 23023854 in Journal of the American Pharmacists Association : JAPhA as Journal Article, Review, with publication-date metadata of 2012 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23023854-2026-11-09-09dc80e204af"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23023854-2026-11-09-09dc80e204af"]}],"sources":[{"id":"pubmed-observation-pmid-23023854-2026-11-09-09dc80e204af","name":"PubMed","sourceClass":"A","title":"Peginesatide acetate, axitinib, and pertuzumab. · retained source version 1:2026-11-09:current:09dc80e204af3dbb6e448df862457bc8d9a5bd3bb8416c2af88908392edf01f6","url":"https://pubmed.ncbi.nlm.nih.gov/23023854/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6e8d8191ec0c82e055d65bdfa53b645713821270778b40405cc159a85bf9e3fa","tierARecordSha256":"83fbe275379411b6f72982ec5e37b72ff79ccd8797fde03ad800aaf53003bda1"},"integrity":{"algorithm":"sha256","contentSha256":"b8992233d8cffd3532845ea69cb0e0bb236e0d0f5b771db7424a238d21d06bca"}},"pubmed-pmid-23243269-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23243269-peginesatide:v1","objectPathId":"pubmed-pmid-23243269-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23243269-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-23243269-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-23243269-peginesatide-v1"},"story":{"slug":"pubmed-pmid-23243269-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2021-10-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa.","sourceIds":["pubmed-observation-pmid-23243269-2021-10-21-160405f6760a"]},{"id":"summary","text":"PubMed lists PMID 23243269 in Clinical journal of the American Society of Nephrology : CJASN as Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-12-14 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23243269-2021-10-21-160405f6760a"]},{"id":"paragraph-1","text":"PubMed lists PMID 23243269 in Clinical journal of the American Society of Nephrology : CJASN as Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-12-14 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23243269-2021-10-21-160405f6760a"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23243269-2021-10-21-160405f6760a"]}],"sources":[{"id":"pubmed-observation-pmid-23243269-2021-10-21-160405f6760a","name":"PubMed","sourceClass":"A","title":"Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa. · retained source version 1:2021-10-21:current:160405f6760aa9ecbe5668b2ad513bc7fa42d7c795c4e8e6c06edb10a8a5f63a","url":"https://pubmed.ncbi.nlm.nih.gov/23243269/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b4d72c2d30bc9a895749142a9eb899b81f60ec317f49acd151f8a2952374949a","tierARecordSha256":"8d62051d57dbd560a989d649a948cf5aef7e1c6ae3099de96a14cdfe9e10632c"},"integrity":{"algorithm":"sha256","contentSha256":"1ed287be9f8cb90d55e4e1b5c612f7a8f60c11432b850c10eaa8e7b4612d57ed"}},"pubmed-pmid-23343061-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23343061-peginesatide:v1","objectPathId":"pubmed-pmid-23343061-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23343061-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-23343061-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-23343061-peginesatide-v1"},"story":{"slug":"pubmed-pmid-23343061-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2026-05-18","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide in patients with anemia undergoing hemodialysis.","sourceIds":["pubmed-observation-pmid-23343061-2026-05-18-0e7025afeb26"]},{"id":"summary","text":"PubMed lists PMID 23343061 in The New England journal of medicine as Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, and 1 more PubMed publication type, with publication-date metadata of 2013-01-24 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23343061-2026-05-18-0e7025afeb26"]},{"id":"paragraph-1","text":"PubMed lists PMID 23343061 in The New England journal of medicine as Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, and 1 more PubMed publication type, with publication-date metadata of 2013-01-24 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23343061-2026-05-18-0e7025afeb26"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23343061-2026-05-18-0e7025afeb26"]}],"sources":[{"id":"pubmed-observation-pmid-23343061-2026-05-18-0e7025afeb26","name":"PubMed","sourceClass":"A","title":"Peginesatide in patients with anemia undergoing hemodialysis. · retained source version 1:2026-05-18:current:0e7025afeb2646063f31f2a358196d9c8166a036c1a3a6c64927a89ebd31a747","url":"https://pubmed.ncbi.nlm.nih.gov/23343061/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"af6bb201221766d520f83c16822154d2d0d8a6baec295b0d775276aa9878138e","tierARecordSha256":"894c98e42b7c2f47dffeaf7aa462c287d7bf03bf723df8cfd2c1d57e43decf5e"},"integrity":{"algorithm":"sha256","contentSha256":"fbafabd8c58eb200d2fe6d5537f3037e55e725d6c67b3bac0d750c731df8ba67"}},"pubmed-pmid-23343062-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23343062-peginesatide:v1","objectPathId":"pubmed-pmid-23343062-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23343062-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-23343062-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-23343062-peginesatide-v1"},"story":{"slug":"pubmed-pmid-23343062-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2026-05-18","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.","sourceIds":["pubmed-observation-pmid-23343062-2026-05-18-fe38b7444462"]},{"id":"summary","text":"PubMed lists PMID 23343062 in The New England journal of medicine as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-01-24 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23343062-2026-05-18-fe38b7444462"]},{"id":"paragraph-1","text":"PubMed lists PMID 23343062 in The New England journal of medicine as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-01-24 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23343062-2026-05-18-fe38b7444462"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23343062-2026-05-18-fe38b7444462"]}],"sources":[{"id":"pubmed-observation-pmid-23343062-2026-05-18-fe38b7444462","name":"PubMed","sourceClass":"A","title":"Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis. · retained source version 1:2026-05-18:current:fe38b7444462da53a614302cb4b6080c4225bb061a79fe7afe7dfd618c5bdc1b","url":"https://pubmed.ncbi.nlm.nih.gov/23343062/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"83aea7300aba95a645eaee8ec32d56ccce0ebb5316f7b7c9125f44747b3f62ab","tierARecordSha256":"fdb775cc274374a6dceaf20b1e2a1ec4dccf7da7ac1f8223720b927a841db924"},"integrity":{"algorithm":"sha256","contentSha256":"aad50f64ff1ff096877b3718808a35e0ec10d812c8e6e875ffd7692b9b28d320"}},"pubmed-pmid-23594010-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23594010-peginesatide:v1","objectPathId":"pubmed-pmid-23594010-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23594010-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-23594010-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-23594010-peginesatide-v1"},"story":{"slug":"pubmed-pmid-23594010-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2018-12-02","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide for anemia in chronic kidney disease.","sourceIds":["pubmed-observation-pmid-23594010-2018-12-02-9f0036084c2e"]},{"id":"summary","text":"PubMed lists PMID 23594010 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2013-04-18 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23594010-2018-12-02-9f0036084c2e"]},{"id":"paragraph-1","text":"PubMed lists PMID 23594010 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2013-04-18 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23594010-2018-12-02-9f0036084c2e"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23594010-2018-12-02-9f0036084c2e"]}],"sources":[{"id":"pubmed-observation-pmid-23594010-2018-12-02-9f0036084c2e","name":"PubMed","sourceClass":"A","title":"Peginesatide for anemia in chronic kidney disease. · retained source version 1:2018-12-02:current:9f0036084c2ebed3ee94ae6b7855622237c54acf5cb1edc03a2dd4a4e1727287","url":"https://pubmed.ncbi.nlm.nih.gov/23594010/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"09c942d9508beeaad440edfb0427da4f36c19a20d66a328e7612fc36f5c41902","tierARecordSha256":"3aeee1e1969092776bbd744ef79ac1f9feb6a689dc0a9c258ae5f431d8f0b93a"},"integrity":{"algorithm":"sha256","contentSha256":"85cb78e21cb7fedd7b802fa5a9e5c59f86d1d7a23f7d1be99787125fd3817584"}},"pubmed-pmid-23594011-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23594011-peginesatide:v1","objectPathId":"pubmed-pmid-23594011-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23594011-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-23594011-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-23594011-peginesatide-v1"},"story":{"slug":"pubmed-pmid-23594011-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2018-12-02","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide for anemia in chronic kidney disease.","sourceIds":["pubmed-observation-pmid-23594011-2018-12-02-c32f638a3c1b"]},{"id":"summary","text":"PubMed lists PMID 23594011 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2013-04-18 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23594011-2018-12-02-c32f638a3c1b"]},{"id":"paragraph-1","text":"PubMed lists PMID 23594011 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2013-04-18 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23594011-2018-12-02-c32f638a3c1b"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23594011-2018-12-02-c32f638a3c1b"]}],"sources":[{"id":"pubmed-observation-pmid-23594011-2018-12-02-c32f638a3c1b","name":"PubMed","sourceClass":"A","title":"Peginesatide for anemia in chronic kidney disease. · retained source version 1:2018-12-02:current:c32f638a3c1ba4d25eb7e582ef4c9e4808296e72c1b4b72402fc9465575e3e28","url":"https://pubmed.ncbi.nlm.nih.gov/23594011/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"26ccae68c9dad6e845e648c75562c78eeba7de8e14898ed32f5cb98eecb82f47","tierARecordSha256":"2cf2fd392635e2805ed19e07b527af58200033d7ddfcbcfda5bc61f21f445361"},"integrity":{"algorithm":"sha256","contentSha256":"284eb758901c8deaa2499fc8dd96600ef398d0a4dc0a8f1ab4c1b6515ab7b3b3"}},"pubmed-pmid-23675762-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23675762-peginesatide:v1","objectPathId":"pubmed-pmid-23675762-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23675762-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-23675762-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-23675762-peginesatide-v1"},"story":{"slug":"pubmed-pmid-23675762-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2017-11-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star?","sourceIds":["pubmed-observation-pmid-23675762-2017-11-16-68d259f36fba"]},{"id":"summary","text":"PubMed lists PMID 23675762 in Expert opinion on pharmacotherapy as Editorial, with publication-date metadata of 2013-05-16 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23675762-2017-11-16-68d259f36fba"]},{"id":"paragraph-1","text":"PubMed lists PMID 23675762 in Expert opinion on pharmacotherapy as Editorial, with publication-date metadata of 2013-05-16 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23675762-2017-11-16-68d259f36fba"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23675762-2017-11-16-68d259f36fba"]}],"sources":[{"id":"pubmed-observation-pmid-23675762-2017-11-16-68d259f36fba","name":"PubMed","sourceClass":"A","title":"Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star? · retained source version 1:2017-11-16:current:68d259f36fbad1dbedfe952f3eb38e6ec10a762bf12d12b150db61eecd5a4099","url":"https://pubmed.ncbi.nlm.nih.gov/23675762/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"96505c0c069ab6e6250fc6365ba182cc2c7a285b13e96b0cd5b46391af0be624","tierARecordSha256":"99344320c4f126747dc302533034842520684b85ef9f28f173eeb931f591b685"},"integrity":{"algorithm":"sha256","contentSha256":"113a309d2fd57d784dc5c36597d069279158c116e15cbe2878776b8e5381b863"}},"pubmed-pmid-23810692-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23810692-peginesatide:v1","objectPathId":"pubmed-pmid-23810692-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23810692-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-23810692-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-23810692-peginesatide-v1"},"story":{"slug":"pubmed-pmid-23810692-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2018-12-02","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"On peginesatide and anemia treatment in CKD.","sourceIds":["pubmed-observation-pmid-23810692-2018-12-02-9a356f2cf3ff"]},{"id":"summary","text":"PubMed lists PMID 23810692 in American journal of kidney diseases : the official journal of the National Kidney Foundation as Editorial, Comment, with publication-date metadata of 2013-06-28 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23810692-2018-12-02-9a356f2cf3ff"]},{"id":"paragraph-1","text":"PubMed lists PMID 23810692 in American journal of kidney diseases : the official journal of the National Kidney Foundation as Editorial, Comment, with publication-date metadata of 2013-06-28 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23810692-2018-12-02-9a356f2cf3ff"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23810692-2018-12-02-9a356f2cf3ff"]}],"sources":[{"id":"pubmed-observation-pmid-23810692-2018-12-02-9a356f2cf3ff","name":"PubMed","sourceClass":"A","title":"On peginesatide and anemia treatment in CKD. · retained source version 1:2018-12-02:current:9a356f2cf3ffe632c0dffc4b7e9c2d640f978f55fde09223da624024a0011639","url":"https://pubmed.ncbi.nlm.nih.gov/23810692/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8b43b8ecff8ad813d0f3fc463f05632fa6e1a60a3404f5bf028fcde28c6bca04","tierARecordSha256":"f89d4396bd76b3d415f08c373ae063e3dfd0720f424e6fa898e18be17b91b77a"},"integrity":{"algorithm":"sha256","contentSha256":"91c63db09539ee00c7b24c29be9aa8f5b8cd3557292caa36fa2608aa1a3c253b"}},"pubmed-pmid-24023516-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-24023516-peginesatide:v1","objectPathId":"pubmed-pmid-24023516-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-24023516-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-24023516-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-24023516-peginesatide-v1"},"story":{"slug":"pubmed-pmid-24023516-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2021-10-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide.","sourceIds":["pubmed-observation-pmid-24023516-2021-10-21-27faf7add2b8"]},{"id":"summary","text":"PubMed lists PMID 24023516 in International journal of nanomedicine as Journal Article, Review, with publication-date metadata of 2013-08-26 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-24023516-2021-10-21-27faf7add2b8"]},{"id":"paragraph-1","text":"PubMed lists PMID 24023516 in International journal of nanomedicine as Journal Article, Review, with publication-date metadata of 2013-08-26 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-24023516-2021-10-21-27faf7add2b8"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-24023516-2021-10-21-27faf7add2b8"]}],"sources":[{"id":"pubmed-observation-pmid-24023516-2021-10-21-27faf7add2b8","name":"PubMed","sourceClass":"A","title":"Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide. · retained source version 1:2021-10-21:current:27faf7add2b8299bf25a22613363d3fb51d5a8835786ac40bd4dafda128b647c","url":"https://pubmed.ncbi.nlm.nih.gov/24023516/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"51c1c79f1a7589ae1b8954bcfa0623a09783869b1e0c8bacfff363b0e438b0ee","tierARecordSha256":"ada83b0aa6dcc6ff81ca52007861e9a542f627ca238b0950218e91e80776e32e"},"integrity":{"algorithm":"sha256","contentSha256":"66c9796f0b7b137f2a1c814ef9320294177b507d10f8ac053d1edc4501f779df"}},"pubmed-pmid-24584613-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-24584613-peginesatide:v1","objectPathId":"pubmed-pmid-24584613-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-24584613-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-24584613-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-24584613-peginesatide-v1"},"story":{"slug":"pubmed-pmid-24584613-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2021-10-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis.","sourceIds":["pubmed-observation-pmid-24584613-2021-10-21-d3f15ad296f0"]},{"id":"summary","text":"PubMed lists PMID 24584613 in Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-03-01 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-24584613-2021-10-21-d3f15ad296f0"]},{"id":"paragraph-1","text":"PubMed lists PMID 24584613 in Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-03-01 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-24584613-2021-10-21-d3f15ad296f0"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-24584613-2021-10-21-d3f15ad296f0"]}],"sources":[{"id":"pubmed-observation-pmid-24584613-2021-10-21-d3f15ad296f0","name":"PubMed","sourceClass":"A","title":"Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis. · retained source version 1:2021-10-21:current:d3f15ad296f09277c682397fd71a5d47e9248b50149ef344fe5ec5907a80fe55","url":"https://pubmed.ncbi.nlm.nih.gov/24584613/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5ca1d2f8a4c9fc1a57b0f6a23e9c0b43b70070e062b9db99227e0ec3d4f21cec","tierARecordSha256":"8a5bf6c3106f76d8aa452b418764fc8e81aff02b73a6db2f4e740fee095ac586"},"integrity":{"algorithm":"sha256","contentSha256":"c37ea18b8e394aee9f884bc070d32c1ef513d1b272e37648b8e6a2e29906191d"}},"pubmed-pmid-27279382-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-27279382-peginesatide:v1","objectPathId":"pubmed-pmid-27279382-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-27279382-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-27279382-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-27279382-peginesatide-v1"},"story":{"slug":"pubmed-pmid-27279382-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2017-11-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Watch out for a revival of peginesatide in sports.","sourceIds":["pubmed-observation-pmid-27279382-2017-11-16-7f266d61ff32"]},{"id":"summary","text":"PubMed lists PMID 27279382 in Drug testing and analysis as Journal Article, with publication-date metadata of 2016-06-09 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27279382-2017-11-16-7f266d61ff32"]},{"id":"paragraph-1","text":"PubMed lists PMID 27279382 in Drug testing and analysis as Journal Article, with publication-date metadata of 2016-06-09 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27279382-2017-11-16-7f266d61ff32"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-27279382-2017-11-16-7f266d61ff32"]}],"sources":[{"id":"pubmed-observation-pmid-27279382-2017-11-16-7f266d61ff32","name":"PubMed","sourceClass":"A","title":"Watch out for a revival of peginesatide in sports. · retained source version 1:2017-11-16:current:7f266d61ff3218b119b68cdab94ec6a0b8cd6299171ca8cdab2aa53b2d13930e","url":"https://pubmed.ncbi.nlm.nih.gov/27279382/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"25803d671c6abd130636b1a35246aaac1a4b8c4135eeae02a719f97109b9a615","tierARecordSha256":"eb3a1f5f077ba11d5db28ca8a39429390919e1e8df7810a3ac3fda7846a35ab5"},"integrity":{"algorithm":"sha256","contentSha256":"2bfdd0d142bc8b10746dd77a1c663564f3a536f4fe624fe235146a3447383917"}},"pubmed-pmid-27551882-peginesatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-27551882-peginesatide:v1","objectPathId":"pubmed-pmid-27551882-peginesatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-27551882-peginesatide/","json":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.json#pubmed-pmid-27551882-peginesatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/peginesatide.md#pubmed-pmid-27551882-peginesatide-v1"},"story":{"slug":"pubmed-pmid-27551882-peginesatide","version":1,"domain":"Literature metadata","dateInSource":"2018-11-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["peginesatide"],"peptides":[{"slug":"peginesatide","url":"https://peptidescanner.com/peptides/peginesatide/"}]},"claims":[{"id":"headline","text":"Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promise.","sourceIds":["pubmed-observation-pmid-27551882-2018-11-13-abd70eff690e"]},{"id":"summary","text":"PubMed lists PMID 27551882 in Expert opinion on drug safety as Comparative Study, Journal Article, Review, with publication-date metadata of 2016-08-23 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27551882-2018-11-13-abd70eff690e"]},{"id":"paragraph-1","text":"PubMed lists PMID 27551882 in Expert opinion on drug safety as Comparative Study, Journal Article, Review, with publication-date metadata of 2016-08-23 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27551882-2018-11-13-abd70eff690e"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-27551882-2018-11-13-abd70eff690e"]}],"sources":[{"id":"pubmed-observation-pmid-27551882-2018-11-13-abd70eff690e","name":"PubMed","sourceClass":"A","title":"Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promise. · retained source version 1:2018-11-13:current:abd70eff690e4ed3dbb951a0c9650ffe097ffaf08cbca2a24f48c9f781954de0","url":"https://pubmed.ncbi.nlm.nih.gov/27551882/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a5babd0f403daad78cff31a18302a5d438cb4cff04a71f4900b21eb153a3c09d","tierARecordSha256":"c2a7800b206b5e11fe44e8d3216271dd4c560365bf959e8c7cf7cdc3c58f4009"},"integrity":{"algorithm":"sha256","contentSha256":"6e6436c41ab28845110d414b99a39e8145deec04c91d6145efb74772ae5430a9"}}}}
